Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
EverQuote CEO Jayme Mendal to Participate in Upcoming Virtual Investor Events
-
Penumbra (PEN) PT Lowered to $204 at Canaccord Genuity
-
QuoteMedia Provides Market Data to Comtex
-
CI Global Asset Management completes US$72 million initial public offering for CI Galaxy Bitcoin Fund
-
Small Cap Momentum Stories to Watch (NASDAQ: BLNK) (OTC US: MMEDF) (OTC US: CLKA) (NASDAQ: CRIS)
-
Castle Biosciences Inc. (CSTL) Prices 4M Share Offering at at $58/Sh
-
Castle Biosciences Announces Pricing of $232 Million Public Offering of Common Stock
-
Ninepoint Partners Announces Ninepoint 2021 Flow-Through Limited Partnership
-
Atalaya Mining PLC Announces Directorate Change
-
Net Asset Value(s)
-
Great Rock Capital Closes CAN$10 Million Senior Secured Revolving Credit Facility with Smart Employee Benefits, Inc.
-
Verano Holdings Enters into an Agreement for a Go-Public Transaction in Conjunction with AltMed Merger
-
Verano Holdings Enters into an Agreement for a Go-Public Transaction in Conjunction with AltMed Merger
-
Castle Biosciences (CSTL) Announces Commencement of $125M Proposed Public Offering of Common Stock
-
Castle Biosciences Announces Commencement of Proposed Public Offering of Common Stock
-
Leaf Group Announces Closing of Public Offering of Common Stock
-
Leaf Group Announces Closing of Public Offering of Common Stock
-
Delcath Systems Announces Completion of Underwritten Public Offering
-
Zuora Management to Hold Fireside Chat Hosted by Canaccord Genuity
-
Increased On‐Market Takeover Bid by Nord Gold SE - Take No Action
-
Pelangio Exploration Completes Final Tranche of Previously Announced Private Placement for Total Aggregate Gross Proceeds of $2,211,700 and Provides Exploration Update
-
Ayr Strategies Announces Closing of 12.5% Senior Secured Notes
-
Euro Manganese Announces Results of Special Meeting
-
Airbnb (ABNB) IPO Opens 115% Higher
-
Mountaingate Capital Portfolio Company Tinuiti Announces Investment From New Mountain Capital
-
Leaf Group (LEAF) Prices 7.145M Share Common Offering at $4.20/Sh
-
Leaf Group Announces Pricing of Public Offering of Common Stock
-
Leaf Group Announces Pricing of Public Offering of Common Stock
-
Metallic Minerals Completes 2020 Exploration Programs at Keno Silver Project in Yukon, Canada with New High-Grade Keno-Style Sulphide Discoveries
-
Airbnb Inc. (ABNB) Prices 51.32M Class A Share IPO at $68/Sh
-
Open Lending Corp. (LPRO) Prices 9.5M Share Upsized Secondary Offering at $28/Sh
-
Top Mushroom Penny Stocks To Watch For 2021
-
Airbnb Announces Pricing of Initial Public Offering
-
Open Lending Corporation Announces Pricing of Upsized Secondary Offering
-
Ayr Strategies Announces Upsizing of Previously Announced 12.5% Senior Secured Notes Offering; Completes Incentive Exercise of Three Million Warrants
-
Leaf Group (LEAF) Announces Proposed Public Offering of Common Stock
-
Leaf Group Announces Proposed Public Offering of Common Stock
-
Leaf Group Announces Proposed Public Offering of Common Stock
-
Leviathan Gold Finance Ltd. Closes Upsized Subscription Receipt Financing of $12,905,500
-
Transaction in Own Shares
-
C3.ai (AI) IPO Opens 138% Higher
-
Delcath Systems (DCTH) Prices Public Offering of Common Stock at $13.25/sh
-
Delcath Systems Announces Pricing of Public Offering of Common Stock
-
C3.ai (AI) Prices 15.5M Class A Share IPO at $42/Sh
-
ATARA Biotherapeutics (ATRA) Prices 5.102M Share Common Offering at $24.50/Sh
-
TransGlobe Energy Corporation Announces Director/PDMR Shareholdings
-
C3.ai Announces Pricing of Initial Public Offering
-
Atara Biotherapeutics Announces Pricing of $175.0 Million Public Offering
-
Sigilon Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Sigilon Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

